Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model
Sophie Le Page, Marjorie Niro, Jérémy Fauconnier, Laura Cellier, Sophie Tamareille, Abdallah Gharib, Arnaud Chevrollier, Laurent Loufrani, Céline Grenier, Rima Kamel, Emmanuelle Sarzi, Alain Lacampagne, Michel Ovize, Daniel Henrion, Pascal Reynier, Guy Lenaers, Delphine Mirebeau-Prunier, Fabrice Prunier, Sophie Le Page, Marjorie Niro, Jérémy Fauconnier, Laura Cellier, Sophie Tamareille, Abdallah Gharib, Arnaud Chevrollier, Laurent Loufrani, Céline Grenier, Rima Kamel, Emmanuelle Sarzi, Alain Lacampagne, Michel Ovize, Daniel Henrion, Pascal Reynier, Guy Lenaers, Delphine Mirebeau-Prunier, Fabrice Prunier
Abstract
Background: Recent data suggests the involvement of mitochondrial dynamics in cardiac ischemia/reperfusion (I/R) injuries. Whilst excessive mitochondrial fission has been described as detrimental, the role of fusion proteins in this context remains uncertain.
Objectives: To investigate whether Opa1 (protein involved in mitochondrial inner-membrane fusion) deficiency affects I/R injuries.
Methods and results: We examined mice exhibiting Opa1delTTAG mutations (Opa1+/-), showing 70% Opa1 protein expression in the myocardium as compared to their wild-type (WT) littermates. Cardiac left-ventricular systolic function assessed by means of echocardiography was observed to be similar in 3-month-old WT and Opa1+/- mice. After subjection to I/R, infarct size was significantly greater in Opa1+/- than in WTs both in vivo (43.2±4.1% vs. 28.4±3.5%, respectively; p<0.01) and ex vivo (71.1±3.2% vs. 59.6±8.5%, respectively; p<0.05). No difference was observed in the expression of other main fission/fusion protein, oxidative phosphorylation, apoptotic markers, or mitochondrial permeability transition pore (mPTP) function. Analysis of calcium transients in isolated ventricular cardiomyocytes demonstrated a lower sarcoplasmic reticulum Ca2+ uptake, whereas cytosolic Ca2+ removal from the Na+/Ca2+ exchanger (NCX) was increased, whilst SERCA2a, phospholamban, and NCX protein expression levels were unaffected in Opa1+/- compared to WT mice. Simultaneous whole-cell patch-clamp recordings of mitochondrial Ca2+ movements and ventricular action potential (AP) showed impairment of dynamic mitochondrial Ca2+ uptake and a marked increase in the AP late repolarization phase in conjunction with greater occurrence of arrhythmia in Opa1+/- mice.
Conclusion: Opa1 deficiency was associated with increased sensitivity to I/R, imbalance in dynamic mitochondrial Ca2+ uptake, and subsequent increase in NCX activity.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Hall AR, Burke N, Dongworth RK, Hausenloy DJ. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 2014;171:1890–1906. 10.1111/bph.12516
- Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012;337:1062–1065. 10.1126/science.1219855
- Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211–215. 10.1038/79944
- Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207–210. 10.1038/79936
- Chao de la Barca JM, Prunier-Mirebeau D, Amati-Bonneau P, Ferre M, Sarzi E, Bris C, et al. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology. Neurobiol Dis 2016;90:20–26. 10.1016/j.nbd.2015.08.015
- Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010;121:2012–2022. 10.1161/CIRCULATIONAHA.109.906610
- Disatnik MH, Ferreira JC, Campos JC, Gomes KS, Dourado PM, Qi X et al. Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J Am Heart Assoc 2013;2:e000461 10.1161/JAHA.113.000461
- Sharp WW, Fang YH, Han M, Zhang HJ, Hong Z, Banathy A et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. Faseb j 2014;28:316–326. 10.1096/fj.12-226225
- Zepeda R, Kuzmicic J, Parra V, Troncoso R, Pennanen C, Riquelme JA et al. Drp1 loss-of-function reduces cardiomyocyte oxygen dependence protecting the heart from ischemia-reperfusion injury. J Cardiovasc Pharmacol 2014;63:477–487. 10.1097/FJC.0000000000000071
- Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O'Shea KM et al. Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol Cell Biol 2011;31:1309–1328. 10.1128/MCB.00911-10
- Chen L, Gong Q, Stice JP, Knowlton AA. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009;84:91–99. 10.1093/cvr/cvp181
- Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 2012;1:e003012 10.1161/JAHA.112.003012
- Piquereau J, Caffin F, Novotova M, Prola A, Garnier A, Mateo P et al. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc Res 2012;94:408–417. 10.1093/cvr/cvs117
- Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A et al. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat 2015;36:20–25. 10.1002/humu.22703
- Sarzi E, Angebault C, Seveno M, Gueguen N, Chaix B, Bielicki G et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. Brain 2012;135:3599–3613. 10.1093/brain/aws303
- Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol 2002;283:H346–352. 10.1152/ajpheart.01050.2001
- Fauconnier J, Lanner JT, Zhang SJ, Tavi P, Bruton JD, Katz A et al. Insulin and inositol 1,4,5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 2005;54:2375–2381. 10.2337/diabetes.54.8.2375
- Paillard M, Tubbs E, Thiebaut PA, Gomez L, Fauconnier J, Da Silva CC et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 2013;128:1555–1565. 10.1161/CIRCULATIONAHA.113.001225
- Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C et al. Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure. J Mol Cell Cardiol 2014;74:162–172. 10.1016/j.yjmcc.2014.05.006
- Fauconnier J, Bedut S, Le Guennec JY, Babuty D, Richard S. Ca2+ current-mediated regulation of action potential by pacing rate in rat ventricular myocytes. Cardiovasc Res 2003;57:670–680. 10.1016/S0008-6363(02)00731-9
- Wilding JR, Joubert F, de Araujo C, Fortin D, Novotova M, Veksler V et al. Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice hearts. J Physiol 2006;575:191–200. 10.1113/jphysiol.2006.114116
- Teixeira G, Chiari P, Fauconnier J, Abrial M, Couture-Lepetit E, Harisseh R et al. Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning. Anesthesiology 2015;123:1374–1384. 10.1097/ALN.0000000000000876
- Gharib A, De Paulis D, Li B, Augeul L, Couture-Lepetit E, Gomez L et al. Opposite and tissue-specific effects of coenzyme Q2 on mPTP opening and ROS production between heart and liver mitochondria: role of complex I. J Mol Cell Cardiol 2012;52:1091–1095. 10.1016/j.yjmcc.2012.02.005
- Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A et al. Role of hypoxia inducible factor-1alpha in remote limb ischemic preconditioning. J Mol Cell Cardiol 2013;65:98–104. 10.1016/j.yjmcc.2013.10.001
- Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D et al. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 2011;106:1329–1339. 10.1007/s00395-011-0210-z
- Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 2015;116:674–699. 10.1161/CIRCRESAHA.116.305348
- Gomez L, Li B, Mewton N, Sanchez I, Piot C, Elbaz M et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res 2009;83:226–233. 10.1093/cvr/cvp063
- Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010;105:151–154. 10.1007/s00395-009-0080-9
- Brady NR, Hamacher-Brady A, Gottlieb RA. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta 2006;1757:667–678. 10.1016/j.bbabio.2006.04.011
- Spiegel R, Saada A, Flannery PJ, Burte F, Soiferman D, Khayat M et al. Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation. J Med Genet 2016;53:127–131. 10.1136/jmedgenet-2015-103361
- Fauconnier J, Roberge S, Saint N, Lacampagne A. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion. Pharmacol Ther 2013;138:323–332. 10.1016/j.pharmthera.2013.01.015
- Prunier F, Kawase Y, Gianni D, Scapin C, Danik SB, Ellinor PT et al. Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation 2008;118:614–624. 10.1161/CIRCULATIONAHA.108.770883
- Bogeholz N, Pauls P, Bauer BK, Schulte JS, Dechering DG, Frommeyer G et al. Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model. Circ Arrhythm Electrophysiol 2015;8:1210–1218. 10.1161/CIRCEP.115.002927
- Yao A, Su Z, Nonaka A, Zubair I, Lu L, Philipson KD et al. Effects of overexpression of the Na+-Ca2+ exchanger on [Ca2+]i transients in murine ventricular myocytes. Circ Res 1998;82:657–665. 10.1161/01.RES.82.6.657
- Pott C, Eckardt L, Goldhaber JI. Triple threat: the Na+/Ca2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure. Curr Drug Targets 2011;12:737–747. 10.2174/138945011795378559
- Qu Z, Xie LH, Olcese R, Karagueuzian HS, Chen PS, Garfinkel A et al. Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve. Cardiovasc Res 2013;99:6–15. 10.1093/cvr/cvt104
- Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000;87:275–281. 10.1161/01.RES.87.4.275
- Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M et al. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metab 2015;21:834–844. 10.1016/j.cmet.2015.05.007
- Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J et al. Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ Res 2015;116:264–278. 10.1161/CIRCRESAHA.116.303356
Source: PubMed